Human Umbilical Artery Endothelial Cells

$525.00

Name of Products

Human Umbilical Artery Endothelial Cells

Catalog Number

HUA1

Product Format

Frozen Vial

Cell Number

5 × 10⁵ cells/vial


Product Description

Primary endothelial cells derived from normal human umbilical artery tissue, shipped frozen at passage 1. Ideal for studies in vascular development, angiogenesis, and endothelial function. For optimal results, we recommend culturing with Nuvyra Labs Endothelial Growth Medium.


Storage Conditions

  • Storage Temperature: −196°C (Liquid Nitrogen Vapor Phase)

  • Shipping Temperature: −80°C

  • Stability: Very stable under proper cryogenic storage conditions


Cell Characterization / Specification

  • VWF/Factor VIII Expression: >95% positive by immunofluorescence

  • Di-I-Ac-LDL Uptake: >95% positive

  • PECAM1 Expression: >95% positive


Quality Control Results

Parameter Method Acceptance Criteria Result
Sterility – Bacteria Growth Plate Negative Negative
Sterility – Fungi Growth Plate Negative Negative
Endotoxin Level Kinetic LAL ≤1.0 EU/μg < 0.05 EU/μg
Mycoplasma (PCR) PCR Negative Negative
HIV-1 / HIV-2 / HBV PCR Negative Negative
Cell Count Manual Count > 5 × 10⁵ 5.0 × 10⁵
Viability Trypan Blue >95% viable 97%

Handling Upon Arrival

Transfer frozen vials immediately to −80°C (short term) or liquid nitrogen (long term). Handle with appropriate PPE.


Thawing & Subculturing Instructions

A) Pre-coat T25 flask with 2 mL Coating Solution, incubate 5 min, rinse with 4 mL rinse solution, and aspirate.
B) Thaw vial in a 37°C water bath, disinfect, and transfer to biosafety cabinet.
C) Add 10 mL Endothelial Growth Medium to flask and seed cells.
D) Once confluent, rinse flask twice with 5 mL rinse solution, add 2 mL Detachment Solution, aspirate after 20 seconds.
E) Wait 1–2 minutes at RT or 37°C, then tap flask to dislodge cells.
F) Add 5 mL Neutralization Solution, centrifuge at 800g for 5 min.
G) Resuspend pellet in 10–15 mL medium, seed into 2–3 flasks (1:2 to 1:3 split).
H) Change medium every 2–3 days; cells typically reach confluence within 7 days.
I) For quiescent cells, switch to Endothelial Basal Medium for 12 hrs before experiments.


Cells are offered for Research Use Only. Not for Clinical Use.

Benefits

Maximizes Cell Viability & Recovery

Preserves Phenotype & Biomarker Expression

Human Umbilical Artery Endothelial Cells

Scientifically engineered formulations, optimized for maximum cellular performance and validated through rigorous quality control.

Optimized for cellular viability and function

Engineered to support robust cell health, proliferation, and performance across passages.

Formulated for consistency and reproducibility

Minimizes variability to ensure reliable outcomes in every experiment.

Validated for purity, sterility, and performance

Extensively tested to meet rigorous quality, safety, and regulatory standards.

Stabilized

Broad cell line compatibility

Scientifically validated

Nutrient-optimized

Consistency you can trust. Each formulation is optimized to deliver reliable outcomes across experiments and timepoints.

Pairs well with